C12R 2001/225
Lactobacillus
C12R2001/225 (Lactobacillus) appears on 761 US grants and 1,339 published applications in this corpus.
Search patents in C12R- Granted patents
- 761
- Published applications
- 1,339
- Assignees
- 665
- Inventors
- 3,195
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 3 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 5 | 0 |
| 1989 | 5 | 0 |
| 1990 | 6 | 0 |
| 1991 | 2 | 0 |
| 1992 | 2 | 0 |
| 1993 | 6 | 0 |
| 1994 | 3 | 0 |
| 1995 | 7 | 0 |
| 1996 | 7 | 0 |
| 1997 | 6 | 0 |
| 1998 | 7 | 0 |
| 1999 | 6 | 0 |
| 2000 | 10 | 0 |
| 2001 | 5 | 5 |
| 2002 | 8 | 4 |
| 2003 | 8 | 15 |
| 2004 | 4 | 25 |
| 2005 | 9 | 24 |
| 2006 | 12 | 20 |
| 2007 | 10 | 20 |
| 2008 | 9 | 29 |
| 2009 | 9 | 34 |
| 2010 | 18 | 33 |
| 2011 | 13 | 37 |
| 2012 | 18 | 36 |
| 2013 | 28 | 42 |
| 2014 | 21 | 44 |
| 2015 | 13 | 47 |
| 2016 | 38 | 47 |
| 2017 | 27 | 56 |
| 2018 | 35 | 45 |
| 2019 | 38 | 65 |
| 2020 | 35 | 68 |
| 2021 | 42 | 86 |
| 2022 | 66 | 136 |
| 2023 | 43 | 133 |
| 2024 | 51 | 121 |
| 2025 | 72 | 109 |
| 2026 | 46 | 58 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Composition for treatment of autoimmune diseases comprising Lactobacillus sakei or extracellular vesicles derived therefrom as active ingredient29 Sep 2026US 12,746,263 B2Liscure Biosciences Co., Ltd.
- Lactobacillus fermentum ATG-V5 strain, or composition for enhancing immunity comprising same1 Sep 2026US 12,721,870 B2Atogen Co., Ltd
- Bioprotective lactic acid bacteria with low postacidification25 Aug 2026US 12,714,120 B2Chr. Hansen A/S
- Lactobacillus paracasei ATG-EI strain or composition comprising same for preventing or treating respiratory disease30 Jun 2026US 12,667,598 B2Atogen Co., Ltd
- Materials and methods for inhibiting a viral infection, including a coronavirus infection16 Jun 2026US 12,653,849 B2Quorum Innovations, LLC
- Novel lactobacillus strains8 Oct 2026US 2026/0305633 A1Dsm IP Assets B.V.
- Orally-delivered vaccines for domesticated and wild animals to prevent pathogen spread using recombinant probiotic bacteria1 Oct 2026US 2026/0295027 A1
- Novel process for producing lactobacillus rhamnosus24 Sep 2026US 2026/0286285 A1Dsm IP Assets B.V.
- Probiotic strain with efficacy in improving depression-like symptoms, microecological preparation and uses thereof17 Sep 2026US 2026/0273001 A1Ningbo University
- Novel bifidobacterium and/or lactobacillus strain or combination thereof and uses thereof17 Sep 2026US 2026/0275273 A1Korea Research Institute of Bioscience and Biotechnology
Most cited
By later US patents
- Lactobacillus strains and methods of selection85US 4,839,281 ANew England Medical Center Hospitals, Inc. · 1989
- Folic acid producing bifidobacterium bacterial strains, formulations and use thereof75US 8,168,171 B2Probiotical S.P.A. · 2012
- Stabilized liquid bacterial suspension for oral administration to animals74US 4,518,696 AChr. Hansen's Laboratory, Inc. · 1985
- Isolation, identification and characterization of strains with probiotic activity, from faeces of infants fed exclusively with breast milk72US 8,637,297 B2Hero GmbH & Co. KG · 2014
- L. acidophilus strains71US 5,032,399 A1991